Skip to Content

Abbisko Cayman Ltd - Stock Quote 02256

Rating as of

Morningstar's Abbisko Cayman Ltd Stock Analysis

Valuation
Currency in HKD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Abbisko Cayman Ltd's Company Profile

Business Description

Abbisko Cayman Ltd is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies.

Contact
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area
Shanghai, China, People's Republic of
T +86 2168911058
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2021
Fiscal Year End Dec 31, 2022
Stock Type
Employees 160